The pediatric preclinical testing program: Description of models and early testing results
Peter J. Houghton(The University of Texas at San Antonio Health Science Center), Malcolm A. Smith(National Cancer Institute), Claire Cole(St. Jude Children's Research Hospital), E. Anders Kolb(Nemours Children's Health System), Javed Khan(Kent State University), Joshua Courtright(Children's Hospital of Philadelphia), Stephen T. Keir(Duke University), Richard B. Lock(Cancer Institute of New South Wales), Tiebin Liu, Richard Görlick(The University of Texas MD Anderson Cancer Center), Debbie Payne(University of Manchester), Edward Favours(St. Jude Children's Research Hospital), Catherine A. Billups(St. Jude Children's Research Hospital), Henry S. Friedman(Duke University), Mimi Tajbakhsh(Children's Cancer Institute Australia), C. Patrick Reynolds(St. Jude Children's Research Hospital), Jianrong Wu(St. Jude Children's Research Hospital), Joseph Zeidner(Duke University), Christopher L. Morton(St. Jude Children's Research Hospital), Charles M. Stopford(Duke University), Jian Zhang(Shandong University), Wendong Zhang(North University of China), Sherry S. Ansher(Center for Cancer Research), John M. Maris(Children's Hospital of Philadelphia), Hernán Carol(Children's Cancer Institute Australia), Chandra L. Tucker(University of Colorado Denver)
Cited by 486
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934